A new classification of cardio-oncology syndromes

[1]  B. Ibáñez,et al.  New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation , 2020, Journal of the American Heart Association.

[2]  P. Ponikowski,et al.  Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) , 2020, European journal of heart failure.

[3]  K. Moore,et al.  Crosstalk Between the Heart and Cancer: Beyond Drug Toxicity. , 2020, Circulation.

[4]  K. Moore,et al.  Myocardial infarction accelerates breast cancer via innate immune reprogramming , 2020, Nature Medicine.

[5]  R. D. de Boer,et al.  Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues , 2020, Current Oncology Reports.

[6]  R. Shofti,et al.  Early Cardiac Remodeling Promotes Tumor Growth and Metastasis , 2020, Circulation.

[7]  N. Samani,et al.  Tumour biomarkers: association with heart failure outcomes , 2020, Journal of internal medicine.

[8]  Sherry‐Ann Brown,et al.  Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors , 2020, Journal of Cardiovascular Translational Research.

[9]  A. Bayés‐Genís,et al.  CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation. , 2020, International journal of cardiology.

[10]  R. Weissleder,et al.  Diminished Reactive Hematopoiesis and Cardiac Inflammation in a Mouse Model of Recurrent Myocardial Infarction. , 2020, Journal of the American College of Cardiology.

[11]  A. Brandes,et al.  Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation. , 2020, European heart journal.

[12]  S. Khaled,et al.  The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy , 2020, Current Hematologic Malignancy Reports.

[13]  Thiago Reis,et al.  Cardiorenal Syndrome , 2020, Definitions.

[14]  R. D. de Boer,et al.  Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease , 2020, Journal of the American Heart Association.

[15]  R. A. Boer,et al.  Troponins and natriuretic peptides to detect cardiotoxicity: useful biomarkers or paradise lost? , 2020, European journal of heart failure.

[16]  Sherry‐Ann Brown.  Preventive Cardio-Oncology: The Time Has Come , 2020, Frontiers in Cardiovascular Medicine.

[17]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[18]  K. Sliwa,et al.  Sex differences in heart failure. , 2019, European heart journal.

[19]  Dae Hyun Lee,et al.  Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). , 2019, Journal of the American College of Cardiology.

[20]  Juan Ye,et al.  Serum Apolipoprotein A-I Combined With C-Reactive Protein Serves As A Novel Prognostic Stratification System For Colorectal Cancer , 2019, Cancer management and research.

[21]  P. Libby,et al.  From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.

[22]  R. D. de Boer,et al.  Cancer and heart disease: associations and relations , 2019, European journal of heart failure.

[23]  P. Libby,et al.  Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.

[24]  E. Ntzani,et al.  Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies , 2019, Scientific Reports.

[25]  Ji He,et al.  Titin mutation associated with responsiveness to checkpoint blockades in solid tumors. , 2019, JCI insight.

[26]  J. Aboumsallem,et al.  Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice , 2019, International journal of molecular sciences.

[27]  H. Kempen,et al.  Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice , 2019, International journal of molecular sciences.

[28]  R. D. de Boer,et al.  Common risk factors for heart failure and cancer , 2019, Cardiovascular research.

[29]  Gabriel A. Hernandez,et al.  Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician , 2019, Clinical Medicine Insights. Cardiology.

[30]  B. Brüne,et al.  Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure , 2018, JAMA cardiology.

[31]  D. Aberle,et al.  Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma , 2018, Science Translational Medicine.

[32]  L. Sakr,et al.  Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study , 2018, British Medical Journal.

[33]  C. Torp-Pedersen,et al.  Incidence of new onset cancer in patients with a myocardial infarction – a nationwide cohort study , 2018, BMC Cardiovascular Disorders.

[34]  G. Berton,et al.  Neoplastic disease after acute coronary syndrome: incidence, duration, and features the ABC-4* Study on Heart Disease , 2018, Journal of cardiovascular medicine.

[35]  M. Monreal,et al.  Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism. , 2018, The American journal of medicine.

[36]  S. Ait-Oudhia,et al.  Mechanisms, monitoring, and management of tyrosine kinase inhibitors–associated cardiovascular toxicities , 2018, OncoTargets and therapy.

[37]  Lyanne M. Kieneker,et al.  Heart Failure Stimulates Tumor Growth by Circulating Factors , 2018, Circulation.

[38]  J. Stulak,et al.  Neoplasia and the Heart: Pathological Review of Effects With Clinical and Radiological Correlation. , 2018, Journal of the American College of Cardiology.

[39]  Hans Anton Schlößer,et al.  Cytokine release syndrome , 2018, Journal of Immunotherapy for Cancer.

[40]  M. Sadelain,et al.  CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade , 2018, Nature Medicine.

[41]  R. Sullivan,et al.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. , 2018, Journal of the American College of Cardiology.

[42]  R. Pazdur,et al.  FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome , 2018, The oncologist.

[43]  T. Oka,et al.  Mechanism and management of cancer-associated thrombosis. , 2018, Journal of cardiology.

[44]  Theresa M. Beckie,et al.  Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association , 2018, Circulation.

[45]  I. Piña,et al.  Sex differences in heart failure , 2018, Clinical cardiology.

[46]  M. Korc,et al.  Cancer-associated cachexia , 2018, Nature Reviews Disease Primers.

[47]  W. Hwang,et al.  Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis , 2017, JAMA oncology.

[48]  E. Yeh,et al.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2. , 2017, Journal of the American College of Cardiology.

[49]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[50]  Peter Libby.  The Present and FutureReview Topic of the WeekInterleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond , 2017 .

[51]  N. Mackman,et al.  Cancer-associated pathways and biomarkers of venous thrombosis. , 2017, Blood.

[52]  H. Kamel,et al.  Risk of Arterial Thromboembolism in Patients With Cancer. , 2017, Journal of the American College of Cardiology.

[53]  Christian Gilissen,et al.  Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life. , 2017, American journal of human genetics.

[54]  G. Weisz,et al.  Associated Risk of Malignancy in Patients with Cardiovascular Disease: Evidence and Possible Mechanism. , 2017, The American journal of medicine.

[55]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[56]  Yassine Belloum,et al.  Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review). , 2017, Oncology reports.

[57]  W. Guo,et al.  Hypertension and breast cancer risk: a systematic review and meta-analysis , 2017, Scientific Reports.

[58]  P. Austin,et al.  Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization , 2017, Journal of the American Heart Association.

[59]  J. Herrmann,et al.  Cardiovascular Toxicities of Small Molecule Tyrosine Kinase Inhibitors: An Opportunity for Systems‐Based Approaches , 2016, Clinical pharmacology and therapeutics.

[60]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[61]  R. Vij,et al.  Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[62]  A. Maas,et al.  Cardiovascular risk of BRCA1/2 mutation carriers: A review. , 2016, Maturitas.

[63]  M. Budoff,et al.  Gender and age effects on risk factor-based prediction of coronary artery calcium in symptomatic patients: A Euro-CCAD study. , 2016, Atherosclerosis.

[64]  M. Pearce,et al.  Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children , 2016, Heart.

[65]  N. Cook,et al.  Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation. , 2016, JAMA cardiology.

[66]  C. Grines,et al.  Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue , 2016, Circulation.

[67]  A. Blaes,et al.  Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.

[68]  L. Køber,et al.  Incidence of cancer in patients with chronic heart failure: a long‐term follow‐up study , 2016, European journal of heart failure.

[69]  R. Schwabe,et al.  Damage-associated molecular patterns in cancer: A double-edged sword , 2016, Oncogene.

[70]  J. Beckman,et al.  Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer , 2016, Circulation.

[71]  J. Morley,et al.  Pathophysiology of anorexia in the cancer cachexia syndrome , 2015, Journal of cachexia, sarcopenia and muscle.

[72]  O. Melander,et al.  BRCA2 gene mutations and coagulation-associated biomarkers , 2015, Thrombosis and Haemostasis.

[73]  N. Benowitz,et al.  Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[74]  S. Nie,et al.  The dose–response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies , 2015, British Journal of Sports Medicine.

[75]  E. Rimm,et al.  Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies , 2015, BMJ : British Medical Journal.

[76]  M. R. Sardar,et al.  Cardiovascular Impact of Eating Disorders in Adults: A Single Center Experience and Literature Review , 2015, Heart views : the official journal of the Gulf Heart Association.

[77]  Alaa M Ali,et al.  Tumor lysis syndrome: A clinical review. , 2015, World journal of critical care medicine.

[78]  A. Qureshi,et al.  Incident Cancer in a Cohort of 3,247 Cancer Diagnosis Free Ischemic Stroke Patients , 2015, Cerebrovascular Diseases.

[79]  D. Alter,et al.  Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults , 2015, Annals of Internal Medicine.

[80]  C. la Vecchia,et al.  Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis , 2014, British Journal of Cancer.

[81]  R. Hinton,et al.  Cardiovascular Manifestations of Tuberous Sclerosis Complex and Summary of the Revised Diagnostic Criteria and Surveillance and Management Recommendations From the International Tuberous Sclerosis Consensus Group , 2014, Journal of the American Heart Association.

[82]  Pamela A Shaw,et al.  Chimeric antigen receptor T cells for sustained remissions in leukemia. , 2014, The New England journal of medicine.

[83]  E. Núñez,et al.  Clinical utility of antigen carbohydrate 125 in heart failure , 2014, Heart Failure Reviews.

[84]  L. Mestroni,et al.  Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy , 2014, Journal of Medical Genetics.

[85]  J. Cerhan,et al.  Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer. , 2014, Journal of the American College of Cardiology.

[86]  D. Teachey,et al.  Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies , 2014, Cancer journal.

[87]  Qing He,et al.  Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia , 2014, Science Translational Medicine.

[88]  Jeff S. Jasper,et al.  27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology , 2013, Science.

[89]  J. Le Heuzey,et al.  Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study , 2013, Circulation.

[90]  Timothy J Nelson,et al.  Patients with heart failure have an increased risk of incident cancer. , 2013, Journal of the American College of Cardiology.

[91]  R. Burger.  Impact of Interleukin-6 in Hematological Malignancies , 2013, Transfusion Medicine and Hemotherapy.

[92]  J. Mathews,et al.  Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians , 2013, BMJ.

[93]  M. LeWinter,et al.  Titin is a major human disease gene. , 2013, Circulation.

[94]  J. Sowers,et al.  Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome , 2013, Cardiorenal Medicine.

[95]  Tetsuro Tsujimoto,et al.  Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis , 2012, PloS one.

[96]  C. Macaya,et al.  Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers , 2012, Journal of Cancer Research and Clinical Oncology.

[97]  T. Ahern,et al.  Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. , 2011, Journal of the National Cancer Institute.

[98]  C. Ronco,et al.  The Cardiorenal Syndrome , 2011, International journal of nephrology.

[99]  M. Melbye,et al.  Use of Angiotensin Receptor Blockers and the Risk of Cancer , 2011, Circulation.

[100]  Karl Swedberg,et al.  Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals , 2011, Journal of hypertension.

[101]  Ya-xiong Shi.  Diabetes and Cancer: A Consensus Report , 2010 .

[102]  D. Yee,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[103]  M. Gatzoulis,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[104]  P. Hartge,et al.  Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma , 2009, PloS one.

[105]  A. McTiernan,et al.  Mechanisms linking physical activity with cancer , 2008, Nature Reviews Cancer.

[106]  Tara Gomes,et al.  Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. , 2007, JAMA.

[107]  F. Stickel,et al.  Molecular mechanisms of alcohol-mediated carcinogenesis , 2007, Nature Reviews Cancer.

[108]  K. Straif,et al.  Carcinogenicity of alcoholic beverages. , 2007, The Lancet. Oncology.

[109]  Licia Iacoviello,et al.  Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. , 2006, Archives of internal medicine.

[110]  Graham A. Colditz,et al.  Physical activity and survival after breast cancer diagnosis , 2005 .

[111]  Graham A Colditz,et al.  Physical activity and survival after breast cancer diagnosis. , 2004, JAMA.

[112]  T. Kanda,et al.  Interleukin-6 and cardiovascular diseases. , 2004, Japanese heart journal.

[113]  S. Karpatkin,et al.  Thrombin induces neoangiogenesis in the chick chorioallantoic membrane , 2003, Journal of thrombosis and haemostasis : JTH.

[114]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[115]  G. Semenza.  Involvement of hypoxia-inducible factor 1 in human cancer. , 2002, Internal medicine.

[116]  R Kucherlapati,et al.  Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. , 2000, The Journal of clinical investigation.

[117]  S. Schulman,et al.  Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. , 2000, The New England journal of medicine.

[118]  J. Olsen,et al.  The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. , 1998, The New England journal of medicine.

[119]  E. Weiderpass,et al.  Venous thromboembolism and cancer , 1998, The Lancet.

[120]  H. Kleinman,et al.  Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. , 1997, The American journal of physiology.

[121]  T. Irving,et al.  Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. , 1995, Biophysical journal.

[122]  J. V. Sørensen,et al.  Venous thromboembolism and cancer. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[123]  C. Gaudio,et al.  The elusive link between sex hormone levels and Takotsubo syndrome. , 2018, International journal of cardiology.

[124]  P. Heuschmann,et al.  Supplementary Appendix , 2015 .

[125]  L. Leinwand,et al.  Molecular and Cellular Pathobiology Cancer Causes Cardiac Atrophy and Autophagy in a Sexually Dimorphic Manner , 2011 .

[126]  M. Gladwin,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[127]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[128]  R. Reisfeld,et al.  Targeted cytokines for cancer immunotherapy , 2000, Immunologic research.